Table 1.
Baseline characteristics of patients enrolled
| ECS | S-ECS | CS | |
|---|---|---|---|
| Number of participants (n) | 1 | 1 | 1 |
| Age, years | 57 | 25 | 23 |
| Gender | Male | Male | Female |
| Smoking | No | No | No |
| BMI | 19.8 | 20.8 | 17.1 |
| Subjective global assessment | B | A | B |
| Location of CD | Ileocolonic | Ileocolonic | Ileocolonic |
| Years of diagnosis | 7 | 12 | 1 |
| Previous surgery | Yes | No | No |
| Prior treatment failure | |||
| Immunosuppressants | Yes | Yes | No |
| Biologics | No | No | No |
| Hospitalization last 6 months | No | No | Yes |
| Hb | 85 | 126 | 90 |
| Albumin | 31 | 31 | 22 |
| CRP | 5.8 | 42 | 25 |
| Fecal calprotectin | 6932 | 693 | 707 |
| Vitamin A | 1.2 | 0.9 | 0.8 |
| Vitamin D | 18.3 | 14.5 | 51 |
| Vitamin B12 | 269 | 233 | 182 |
| Chromium | 2.1 | 2.7 | 7.7 |
| Copper | 18.1 | 2.7 | – |
| Zinc | 8.6 | 8.6 | 5.7 |
| SHAPE markers | 1 | 0 | 0 |
| Beck (depression) | 15 | 22 | 27 |
| CDAI | 447 | 261 | 440 |
| SIBDQ score | 3.6 | 3.2 | 2.1 |
| HAD score–anxiety | 10 | 11 | 6 |
| HAD score–depression | 8 | 7 | 11 |
| Volume Modulen (mL/day) | 1893 | 2578 | 0 |
| Study finished | Yes | No | No |
BMI, Body mass index; CD, Crohn’s disease; CDAI, Crohn's Disease Activity Index; CRP, C-reactive protein; CS, corticosteroids; ECS, exclusive enteral nutrition (EEN) + CS arm; HAD, Hospital Anxiety and Depression score; S-ECS, short-course-CS + EEN arm; SIBDQ, Short form of the Inflammatory Bowel Disease Questionnaire.